Literature DB >> 1357775

HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: an alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation.

O Olerup1, H Zetterquist.   

Abstract

In most PCR-based tissue typing techniques the PCR amplification is followed by a post-amplification specificity step. In typing by PCR amplification with sequence-specific primers (PCR-SSP), typing specificity is part of the amplification step, which makes the technique almost as fast as serological tissue typing. In the present study primers were designed for DR "low-resolution" typing by PCR-SSP, i.e. identifying polymorphism corresponding to the serologically defined series DR1-DRw18. This resolution was achieved by performing 19 PCR reactions per individual, 17 for assigning DR1-DRw18 and 2 for the DRw52 and DRw53 superspecificities. Thirty cell lines and 121 individuals were typed by the DR "low-resolution" PCR-SSP technique, TaqI DRB-DQA-DQB RFLP analysis and serology. The concordance between PCR-SSP typing and RFLP analysis was 100%. The reproducibility was 100% in 40 samples typed on two separate occasions. No false-positive or false-negative typing results were obtained. All homozygous and heterozygous combinations of DR1-DRw18 could be distinguished. Amplification patterns segregated according to dominant Mendelian inheritance. DNA preparation, PCR amplification and post-amplification processing, including gel detection, documentation and interpretation, were performed in 2 hours. In conclusion, PCR-SSP is an accurate typing technique with high sensitivity, specificity and reproducibility. The method is rapid and inexpensive. DR "low-resolution" typing by the PCR-SSP technique is ideally suited for analyzing small numbers of samples simultaneously and is an alternative to serological DR typing in routine clinical practice including donor-recipient matching in cadaveric transplantations.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1357775     DOI: 10.1111/j.1399-0039.1992.tb01940.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  253 in total

1.  Alkaline-mediated differential interaction (AMDI): a simple automatable single-nucleotide polymorphism assay.

Authors:  S Bartlett; J Straub; S Tonks; R S Wells; J G Bodmer; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-20       Impact factor: 11.205

2.  T-cell reactivity against streptococcal antigens in the periphery mirrors reactivity of heart-infiltrating T lymphocytes in rheumatic heart disease patients.

Authors:  L Guilherme; S E Oshiro; K C Faé; E Cunha-Neto; G Renesto; A C Goldberg; A C Tanaka; P M Pomerantzeff; M H Kiss; C Silva; F Guzman; M E Patarroyo; S Southwood; A Sette; J Kalil
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

3.  MICB typing by PCR amplification with sequence specific primers.

Authors:  Segundo González; Sandra Rodríguez-Rodero; Jesús Martínez-Borra; Antonio López-Vázquez; Luis Rodrigo; Carlos López-Larrea
Journal:  Immunogenetics       Date:  2003-03-06       Impact factor: 2.846

4.  Differential HLA allele frequency in Mycobacterium africanum vs Mycobacterium tuberculosis in Mali.

Authors:  Amadou Kone; Bassirou Diarra; Keira Cohen; Seydou Diabate; Bourahima Kone; Mahamane T Diakite; Hawa Diarra; Moumine Sanogo; Antieme C G Togo; Yeya Dit Sadio Sarro; Bocar Baya; Nadie Coulibaly; Ousmane Kodio; Chad J Achenbach; Robert L Murphy; Jane L Holl; Sophia Siddiqui; Seydou Doumbia; William R Bishai; Souleymane Diallo; Mamoudou Maiga
Journal:  HLA       Date:  2019-01-02       Impact factor: 4.513

5.  Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors.

Authors:  D Montagna; R Maccario; P Comoli; L Prete; M Zecca; E Giraldi; C Daielli; A Moretta; P De Stefano; F Locatelli
Journal:  J Clin Immunol       Date:  1996-03       Impact factor: 8.317

6.  Twin concordance and sibling recurrence rates in multiple sclerosis.

Authors:  C J Willer; D A Dyment; N J Risch; A D Sadovnick; G C Ebers
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-20       Impact factor: 11.205

7.  Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1*13 but not with tumour necrosis factor alpha -308 promoter polymorphism.

Authors:  P L Bittencourt; S A Palacios; E L R Cançado; F J Carrilho; G Porta; J Kalil; A C Goldberg
Journal:  Gut       Date:  2002-10       Impact factor: 23.059

8.  Modes of action of HLA-DR susceptibility specificities in multiple sclerosis.

Authors:  Helena Modin; Wiveka Olsson; Jan Hillert; Thomas Masterman
Journal:  Am J Hum Genet       Date:  2004-06       Impact factor: 11.025

9.  HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.

Authors:  S Laivoranta-Nyman; T Möttönen; R Hermann; J Tuokko; R Luukkainen; M Hakala; P Hannonen; M Korpela; U Yli-Kerttula; A Toivanen; J Ilonen
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

10.  Variability in the CIITA gene interacts with HLA in multiple sclerosis.

Authors:  A Gyllenberg; F Piehl; L Alfredsson; J Hillert; I L Bomfim; L Padyukov; M Orho-Melander; E Lindholm; M Landin-Olsson; Å Lernmark; T Olsson; I Kockum
Journal:  Genes Immun       Date:  2014-01-16       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.